Professional Overview
Angela Howerton is a seasoned finance and accounting executive with over 15 years of experience in the pharmaceutical and life sciences industries. She currently serves as the Vice President Finance Controller at Cellphire Therapeutics, Inc., where she oversees all financial reporting, budgeting, and internal controls for the organization. Additionally, she holds the position of Director of Finance at ExeGi Pharma, LLC, and has previously held roles as the Global Controller for the BioSciences Division at Thermo Fisher Scientific.
Experience Summary
Current Role
As the Vice President Finance Controller at Cellphire Therapeutics, Inc., Angela is responsible for the company's financial reporting, budget management, and internal control implementation. She has played a pivotal role in streamlining financial processes, improving operational efficiency, and ensuring the organization's financial health and compliance. Under her leadership, Cellphire has achieved significant cost savings and improved financial visibility, contributing to the company's overall growth and success.
Career Progression
Prior to her current roles, Angela held various finance and accounting positions, including Assistant Controller, Banking and Tax Manager at Micro Focus, and Accounting Manager and Budget Analyst at Catalyst Rx. Her diverse experience has equipped her with a comprehensive understanding of financial management, regulatory compliance, and strategic decision-making in the pharmaceutical and life sciences sectors.
Academic Background
Angela holds a Bachelor's degree in Accounting from the University of Maryland, Baltimore County. She is a Certified Public Accountant (CPA) and has completed additional training in financial analysis, budgeting, and strategic planning.
Areas of Expertise
- Financial reporting and analysis
- Budgeting and forecasting
- Internal controls and compliance
- Financial process optimization
- Strategic financial planning
- Pharmaceutical and life sciences industry knowledge
Professional Impact
During her tenure at Thermo Fisher Scientific, Angela played a key role in the successful integration of the BioSciences Division's financial systems and processes, resulting in improved operational efficiency and enhanced financial visibility. She has also been instrumental in implementing robust internal control frameworks and streamlining financial reporting at both Cellphire Therapeutics and ExeGi Pharma, enabling these organizations to make informed, data-driven decisions.
Conclusion
With her extensive finance and accounting expertise, coupled with her deep understanding of the pharmaceutical and life sciences industries, Angela Howerton is a valuable asset to the organizations she serves. Her ability to optimize financial processes, improve operational efficiency, and provide strategic financial guidance positions her as a trusted leader in her field.
